Developer docs
API playgroundTry for free, no card

Search company profiles

Neuroscape

Full company profile

uuid0004gm7

Namestring
Neuroscape
Legal namestring
Neuroscape, UCSF
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Neuroscape is a translational neuroscience center at the University of California, San Francisco (UCSF) that develops and validates closed-loop video game platforms, multimodal biosensing tools, and cognitive assessment instruments for brain function assessment and optimization. Founded through the September 2016 unification of Dr. Adam Gazzaley's Gazzaley Lab (2005), the Neuroscience Imaging Center (2007), and the Neuroscape Lab (2014), the center is led by Dr. Adam Gazzaley (David Dolby Distinguished Professor) and operates from the Sandler Neurosciences Center and the Nancy Friend Pritzker Psychiatry Building on the UCSF Mission Bay campus. Its portfolio spans the Nexus remote clinical-trial platform, the ACE and ORCA mobile cognitive assessment batteries, the Glass Brain 3D visualization tool, and roughly fifteen intervention games including Neuroracer, MediTrain, Body Brain Trainer, Coherence, Labyrinth, and Virtual Attention Trainer, all built as adaptive closed-loop systems driven by multimodal biosensing (EEG, ECG, EMG, EOG, respiration, blood pressure, EDA) and deep-learning cognitive-state prediction.

The center targets both healthy populations seeking cognitive enhancement and clinical populations with conditions including ADHD, autism, depression, dyslexia, mild cognitive impairment and dementia, multiple sclerosis, traumatic brain injury, and cancer-related cognitive impairment. As an academic research center rather than a commercial company, Neuroscape generates operating support through NIH grants (National Institute on Aging, National Institute of Mental Health), philanthropy via the Neuroscape Network (Dolby Family, Steve Jurvetson, Mark Hall, Mickey Hart), and industry collaboration. Its principal commercial pathway is technology licensing: the Neuroracer patent was licensed from UCSF to Akili Interactive Labs (co-founded by Dr. Gazzaley), which produced EndeavorRx (FDA-cleared June 2020 for pediatric ADHD), the 2023 adolescent expansion, and EndeavorOTC (FDA-approved OTC for adults in 2024) — making it the first video game ever cleared by the FDA as a treatment for any medical condition. A $225,000 grant from the Patrick J. McGovern Foundation in December 2021 is the only specific funding event disclosed.

Neuroscape's go-to-market is primarily academic and licensing-led: technologies are developed as research prototypes tested through scientific experiments, and successful ones with demonstrated efficacy signals are licensed through UCSF's technology transfer office to industry partners for commercialization. The Neuroscape Alliance — a network of nine academic institutions across the USA, France, Switzerland, Israel, the UK, and Australia — supports multi-site clinical trials, technology sharing, and translational research at global scale, while industry partnerships with Akili, Sony, Meta, NVIDIA, Zynga, Brain Vision, Cognionics, Empatica, Neuroelectrics, High Fidelity, Meyer Sound, Qusp, Jazz, and Alternova supply hardware, software, and domain expertise. Pricing is non-commercial: all diagnostics and interventions are research tools rather than sold products, so the center's economics depend on grant cycles, philanthropic contributions, and royalty flows from licensees rather than direct sales.

Short descriptiontext

Neuroscape is a UCSF-affiliated translational neuroscience center developing closed-loop video games, multimodal biosensing, and cognitive assessment tools for brain assessment and optimization, serving clinical populations with ADHD, autism, depression, and other neurological conditions through research and technology licensing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCoimbatore, India
HQ citystring
Coimbatore
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cognitive assessment tools, digital therapeutics research, closed-loop brain training, multimodal biosensing platform, translational neuroscience
Industry4 codes
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAEAJ
Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Services-Commercial Physical & Biological Research8731
Product category
Digital Therapeutics Research
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Research Grants and Philanthropy
TypeSubscription Recurring
Description

Funding from NIH (National Institute on Aging, National Institute of Mental Health), foundations (Biggelsworth Family Foundation, The Laney Thornton Foundation), and The Neuroscape Network (a group of philanthropists).

neuroscape.ucsf.edu
2Technology Licensing
TypeLicensing Royalties
Description

Licensing of patented technologies to industry partners such as Akili Interactive Labs (Neuroracer licensed, leading to FDA-cleared EndeavorRx). Technologies with demonstrated efficacy signals may be licensed through UCSF to companies for product development.

neuroscape.ucsf.edu
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 13 records shown
1Neuroracer
Description

The first cognitive optimization video game developed by Neuroscape, designed to challenge multitasking abilities. Its methodology was licensed to Akili Interactive Labs and evolved into EndeavorRx, FDA-cleared for ADHD treatment.

neuroscape.ucsf.edu
+12 more records
Core offering1 text field

Neuroscape is a UCSF translational neuroscience research center that develops custom-designed, closed-loop video game platforms, mobile cognitive assessment tools, and multimodal biosensing systems to assess and optimize brain function. Its prototypes are validated through clinical research and licensed to industry partners for commercial productization (e.g., Neuroracer → Akili's FDA-cleared EndeavorRx). Core offerings include the Nexus research deployment platform, ACE and ORCA mobile assessments, Glass Brain visualization, and a portfolio of intervention games (Neuroracer, MediTrain, Coherence, Labyrinth, Body Brain Trainer) integrated with the Multimodal Biosensing (MMBS) platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Neuroracer training improved vigilance and working memory in older adults - published in Nature 2013
+4 more records
Product overview1 text field

Neuroscape is a translational neuroscience center at UCSF developing closed-loop video game platforms and assessment tools for cognitive optimization. Their portfolio includes Nexus (research deployment platform), ACE and ORCA (cognitive assessment tools), Glass Brain (3D brain visualization), and multiple intervention games (Neuroracer, MediTrain, Body Brain Trainer, Coherence, Labyrinth, Engage, Virtual Attention Trainer, Beep Seeker, Big Fish Competition, Boing, Worder, Rhythmicity, Nature Journey) all designed as closed-loop systems that adapt to individual performance. The Multimodal Biosensing (MMBS) platform powers real-time physiological data collection for emotion and attention prediction.

Product and service6 records
1Nexus
CategoryResearch deployment platform
Description

HIPAA-compliant AWS-hosted research platform that deploys large-scale clinical trials and assessment studies, enabling completely remote research workflows including recruitment, authentication, consenting, characterization, randomization, treatment, outcomes, and follow-up via digital interface.

2ACE (Adaptive Cognitive Evaluation)
CategoryDiagnostic tool
Description

Mobile cognitive control assessment battery that uses adaptive algorithms to evaluate attention, working memory, and goal management in approximately 5 minutes without ceiling or floor effects.

3Glass Brain
CategoryDiagnostic tool
Description

3D brain visualization technology combining MRI and EEG neuroimaging to display personalized, real-time brain activity and connectivity between brain areas, built on Unity 3D game engine powered by NVIDIA GPU computing.

4ORCA (Older Adult Research Characterization App)
CategoryDiagnostic tool
Description

Digital application for smartphones and tablets that assesses cognitive performance of older adults for research eligibility using speech-to-text technology, serving as a digital analog of standardized neuropsychological paper-and-pencil tests.

5Neuroracer
CategoryCognitive intervention
Description

Custom-designed closed-loop video game challenging multitasking abilities through simultaneous navigation and sign-response tasks with adaptive difficulty algorithms; the methodology was licensed to Akili Interactive Labs and became the foundation for EndeavorRx.

6MediTrain
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Founded by Dr. Adam Gazzaley to commercialize Neuroracer technology. Akili developed EndeavorRx (based on Neuroracer) which received FDA clearance in June 2020 as the first video game treatment for ADHD in children, and EndeavorOTC for adults (2024). The Neuroracer patent was licensed from UCSF to Akili.

2University of Nice Sophia Antipolis - CoBTeK IA
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic alliance member focusing on clinical and translational research using ICT for neuropsychiatric and neuro-developmental disorders. Collaborates on research projects, shares knowledge, and exchanges students.

neuroscape.ucsf.edu
3Center Hospitalier Universitaire Vaudois (CHUV) - NeuroTech
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical research organization in Lausanne, Switzerland dedicated to medical, medico-economic, societal and ethical assessment of novel technologies in clinical neuroscience. First of its kind in Europe. Neuroscape@NeuroTech lab established at CHUV.

neuroscape.ucsf.edu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic alliance member focusing on integrative medicine approaches combined with neuroscience research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance member focused on determining neuronal, cognitive, genetic, and environmental components underlying language and reading development in children using neuroimaging techniques.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Top-ranked children's hospital leveraging high tech companies to improve patient care through technology innovation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic alliance focused on understanding human-robot interaction and social cognition research using psychology, cognitive neuroscience and social robotics.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance member led by Dr. Sandra Bond Chapman, conducting research to discover and implement proactive ways to build a stronger, faster, higher performing brain. Includes Brain Performance Institute.

9Monash University - Turner Institute for Brain and Mental Health
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance member (one of Australia's largest mental health institutes) developing lifestyle and technology-based interventions for substance and behavioral addictions through BrainPark initiative.

neuroscape.ucsf.edu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance member developing human-centered games, VR systems and interactive media to maintain and improve health and wellbeing of people with special needs, older adults, and people with disabilities.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Akili was co-founded by Dr. Adam Gazzaley and commercialized Neuroscape's Neuroracer technology as EndeavorRx and EndeavorOTC — the first FDA-cleared video game treatments for ADHD. Direct peer given the technology origin and indication overlap (pediatric and adult ADHD digital therapeutics).

TypeDirect peer
Description

Posit Science develops BrainHQ, a cognitive training platform with peer-reviewed efficacy data across older adults, similar in commercial model and target population to Neuroscape's Body Brain Trainer. Closest analog in the cognitive training category by both mechanism (adaptive exercises) and end market.

TypeDirect peer
Description

CogniFit offers a commercial cognitive assessment and brain training platform targeting both healthy users and clinical populations (ADHD, TBI, MS, dementia). Comparable to Neuroscape in combining assessments (similar to ACE/ORCA) with adaptive training games.

TypeDirect peer
Description

Cambridge Cognition develops digital cognitive assessments (CANTAB) used in clinical trials and clinical practice, comparable to Neuroscape's ACE and ORCA assessment tools. Both target CNS clinical trials and clinical decision support markets.

TypeDirect peer
Description

Click Therapeutics is a prescription digital therapeutics company developing software-based treatments across migraine, schizophrenia, MDD, and oncology — directly comparable business model (DTx with FDA pathway) to what Neuroscape technologies pursue after licensing.

TypeDirect peer
Description

MedRhythms develops digital therapeutics for neurologic conditions (notably stroke-related walking impairment) using sensor-based rhythmic auditory stimulation. Comparable to Neuroscape's Coherence rhythm training and VR Labyrinth interventions in mechanism (closed-loop audio/motor) and clinical focus.

7Pear Therapeutics
TypeBroad incumbent
Description

Pear Therapeutics pioneered the prescription digital therapeutics category with FDA-authorized products for substance use disorder, opioid use disorder, and insomnia. Although the company filed for bankruptcy in 2023, it established the regulatory pathway that Neuroscape-licensed products now follow.

TypeDirect peer
Description

Soterix Medical develops non-invasive brain stimulation and neuromodulation devices (tDCS, tACS, HD-tES) used in research and clinical applications. Comparable to Neuroscape's Neuroelectrics-partnered transcranial brain stimulation work in non-invasive brain stimulation hardware.

TypeBroad incumbent
Description

Brainlab offers surgical planning, imaging, and neuroscience visualization tools used in clinical and research settings, including 3D brain visualization broadly comparable to Neuroscape's Glass Brain platform for real-time brain activity display.

TypeOthers
Description

Empatica develops research-grade wearable biosensors (E4 wristband) used by Neuroscape in the MMBS platform. A technology partner but adjacent peer in physiological-signal-based digital biomarker collection for clinical and consumer health applications.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Neuroscape

Digital Therapeutics Researchneuroscape.ucsf.edu

Neuroscape is a UCSF-affiliated translational neuroscience center developing closed-loop video games, multimodal biosensing, and cognitive assessment tools for brain assessment and optimization, serving clinical populations with ADHD, autism, depression, and other neurological conditions through research and technology licensing.

What Neuroscape does

Neuroscape is a translational neuroscience center at the University of California, San Francisco (UCSF) that develops and validates closed-loop video game platforms, multimodal biosensing tools, and cognitive assessment instruments for brain function assessment and optimization. Founded through the September 2016 unification of Dr. Adam Gazzaley's Gazzaley Lab (2005), the Neuroscience Imaging Center (2007), and the Neuroscape Lab (2014), the center is led by Dr. Adam Gazzaley (David Dolby Distinguished Professor) and operates from the Sandler Neurosciences Center and the Nancy Friend Pritzker Psychiatry Building on the UCSF Mission Bay campus. Its portfolio spans the Nexus remote clinical-trial platform, the ACE and ORCA mobile cognitive assessment batteries, the Glass Brain 3D visualization tool, and roughly fifteen intervention games including Neuroracer, MediTrain, Body Brain Trainer, Coherence, Labyrinth, and Virtual Attention Trainer, all built as adaptive closed-loop systems driven by multimodal biosensing (EEG, ECG, EMG, EOG, respiration, blood pressure, EDA) and deep-learning cognitive-state prediction.

The center targets both healthy populations seeking cognitive enhancement and clinical populations with conditions including ADHD, autism, depression, dyslexia, mild cognitive impairment and dementia, multiple sclerosis, traumatic brain injury, and cancer-related cognitive impairment. As an academic research center rather than a commercial company, Neuroscape generates operating support through NIH grants (National Institute on Aging, National Institute of Mental Health), philanthropy via the Neuroscape Network (Dolby Family, Steve Jurvetson, Mark Hall, Mickey Hart), and industry collaboration. Its principal commercial pathway is technology licensing: the Neuroracer patent was licensed from UCSF to Akili Interactive Labs (co-founded by Dr. Gazzaley), which produced EndeavorRx (FDA-cleared June 2020 for pediatric ADHD), the 2023 adolescent expansion, and EndeavorOTC (FDA-approved OTC for adults in 2024) — making it the first video game ever cleared by the FDA as a treatment for any medical condition. A $225,000 grant from the Patrick J. McGovern Foundation in December 2021 is the only specific funding event disclosed.

Neuroscape's go-to-market is primarily academic and licensing-led: technologies are developed as research prototypes tested through scientific experiments, and successful ones with demonstrated efficacy signals are licensed through UCSF's technology transfer office to industry partners for commercialization. The Neuroscape Alliance — a network of nine academic institutions across the USA, France, Switzerland, Israel, the UK, and Australia — supports multi-site clinical trials, technology sharing, and translational research at global scale, while industry partnerships with Akili, Sony, Meta, NVIDIA, Zynga, Brain Vision, Cognionics, Empatica, Neuroelectrics, High Fidelity, Meyer Sound, Qusp, Jazz, and Alternova supply hardware, software, and domain expertise. Pricing is non-commercial: all diagnostics and interventions are research tools rather than sold products, so the center's economics depend on grant cycles, philanthropic contributions, and royalty flows from licensees rather than direct sales.

Neuroscape firmographics

Firmographics
Name
Neuroscape
Legal name
Neuroscape, UCSF
Website
https://neuroscape.ucsf.edu
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Neuroscape is a UCSF-affiliated translational neuroscience center developing closed-loop video games, multimodal biosensing, and cognitive assessment tools for brain assessment and optimization, serving clinical populations with ADHD, autism, depression, and other neurological conditions through research and technology licensing.
Ownership category
akta.pro rank

Neuroscape industry classification

Industry
Product category
Digital Therapeutics Research
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Other Scientific and Technical Consulting Services (54169)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAEAJ
Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

  • Cognitive assessment tools
  • Digital therapeutics research
  • Closed-loop brain training
  • Multimodal biosensing platform
  • Translational neuroscience

Where Neuroscape is headquartered

Location

Headquarters

HQ city
Coimbatore
HQ country
India
HQ region
Asia

Offices3 records

Markets served

Neuroscape business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

  1. Research Grants and Philanthropy: Funding from NIH (National Institute on Aging, National Institute of Mental Health), foundations (Biggelsworth Family Foundation, The Laney Thornton Foundation), and The Neuroscape Network (a group of philanthropists).
  2. Technology Licensing: Licensing of patented technologies to industry partners such as Akili Interactive Labs (Neuroracer licensed, leading to FDA-cleared EndeavorRx). Technologies with demonstrated efficacy signals may be licensed through UCSF to companies for product development.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Neuroscape product offering

Product offering

Core offering

Neuroscape is a UCSF translational neuroscience research center that develops custom-designed, closed-loop video game platforms, mobile cognitive assessment tools, and multimodal biosensing systems to assess and optimize brain function. Its prototypes are validated through clinical research and licensed to industry partners for commercial productization (e.g., Neuroracer → Akili's FDA-cleared EndeavorRx). Core offerings include the Nexus research deployment platform, ACE and ORCA mobile assessments, Glass Brain visualization, and a portfolio of intervention games (Neuroracer, MediTrain, Coherence, Labyrinth, Body Brain Trainer) integrated with the Multimodal Biosensing (MMBS) platform.

Product overview

Neuroscape is a translational neuroscience center at UCSF developing closed-loop video game platforms and assessment tools for cognitive optimization. Their portfolio includes Nexus (research deployment platform), ACE and ORCA (cognitive assessment tools), Glass Brain (3D brain visualization), and multiple intervention games (Neuroracer, MediTrain, Body Brain Trainer, Coherence, Labyrinth, Engage, Virtual Attention Trainer, Beep Seeker, Big Fish Competition, Boing, Worder, Rhythmicity, Nature Journey) all designed as closed-loop systems that adapt to individual performance. The Multimodal Biosensing (MMBS) platform powers real-time physiological data collection for emotion and attention prediction.

Differentiator

Problem solved

Functional benefit

Brands

  • Neuroracer: The first cognitive optimization video game developed by Neuroscape, designed to challenge multitasking abilities. Its methodology was licensed to Akili Interactive Labs and evolved into EndeavorRx, FDA-cleared for ADHD treatment.
  • EndeavorRx
  • Nexus
  • ACE (Adaptive Cognitive Evaluation)
  • Glass Brain
  • ORCA (Older Adult Research Characterization App)
  • MediTrain
  • Coherence
  • Labyrinth
  • Body Brain Trainer (BBT)
  • Neuroscape Alliance
  • Neuroscape Network
  • UCSF Neuroscape Roybal Center

Products and services

  • Nexus HIPAA-compliant AWS-hosted research platform that deploys large-scale clinical trials and assessment studies, enabling completely remote research workflows including recruitment, authentication, consenting, characterization, randomization, treatment, outcomes, and follow-up via digital interface.
  • ACE (Adaptive Cognitive Evaluation) Mobile cognitive control assessment battery that uses adaptive algorithms to evaluate attention, working memory, and goal management in approximately 5 minutes without ceiling or floor effects.
  • Glass Brain 3D brain visualization technology combining MRI and EEG neuroimaging to display personalized, real-time brain activity and connectivity between brain areas, built on Unity 3D game engine powered by NVIDIA GPU computing.
  • ORCA (Older Adult Research Characterization App) Digital application for smartphones and tablets that assesses cognitive performance of older adults for research eligibility using speech-to-text technology, serving as a digital analog of standardized neuropsychological paper-and-pencil tests.
  • Neuroracer Custom-designed closed-loop video game challenging multitasking abilities through simultaneous navigation and sign-response tasks with adaptive difficulty algorithms; the methodology was licensed to Akili Interactive Labs and became the foundation for EndeavorRx.
  • MediTrain

Quantifiable outcome

  • Neuroracer training improved vigilance and working memory in older adults - published in Nature 2013
  • +4 more outcomes

Companies that use Neuroscape

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles3 records

Neuroscape technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature7 records

Neuroscape partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core.

  • Akili Interactive LabscoreOEM/ Whitelabel/ Licensing PartnerFounded by Dr. Adam Gazzaley to commercialize Neuroracer technology. Akili developed EndeavorRx (based on Neuroracer) which received FDA clearance in June 2020 as the first video game treatment for ADHD in children, and EndeavorOTC for adults (2024). The Neuroracer patent was licensed from UCSF to Akili.
  • University of Nice Sophia Antipolis - CoBTeK IAcoreStrategic or Co-development PartnerAcademic alliance member focusing on clinical and translational research using ICT for neuropsychiatric and neuro-developmental disorders. Collaborates on research projects, shares knowledge, and exchanges students.
  • Center Hospitalier Universitaire Vaudois (CHUV) - NeuroTechcoreStrategic or Co-development PartnerClinical research organization in Lausanne, Switzerland dedicated to medical, medico-economic, societal and ethical assessment of novel technologies in clinical neuroscience. First of its kind in Europe. Neuroscape@NeuroTech lab established at CHUV.
  • Osher Center for Integrative Medicine at UCSFcoreStrategic or Co-development PartnerAcademic alliance member focusing on integrative medicine approaches combined with neuroscience research.
  • Technion - Israel Institute of Technology - Educational Neuroimaging CentercoreStrategic or Co-development PartnerAlliance member focused on determining neuronal, cognitive, genetic, and environmental components underlying language and reading development in children using neuroimaging techniques.
  • UCSF Benioff Children's HospitalcoreStrategic or Co-development PartnerTop-ranked children's hospital leveraging high tech companies to improve patient care through technology innovation.
  • University of Glasgow - Social Brain in Action LaboratorycoreStrategic or Co-development PartnerAcademic alliance focused on understanding human-robot interaction and social cognition research using psychology, cognitive neuroscience and social robotics.
  • The University of Texas at Dallas - Center for BrainHealthcoreStrategic or Co-development PartnerAlliance member led by Dr. Sandra Bond Chapman, conducting research to discover and implement proactive ways to build a stronger, faster, higher performing brain. Includes Brain Performance Institute.
  • Monash University - Turner Institute for Brain and Mental HealthcoreStrategic or Co-development PartnerAlliance member (one of Australia's largest mental health institutes) developing lifestyle and technology-based interventions for substance and behavioral addictions through BrainPark initiative.
  • University of California, Santa Cruz - ASSIST LabcoreStrategic or Co-development PartnerAlliance member developing human-centered games, VR systems and interactive media to maintain and improve health and wellbeing of people with special needs, older adults, and people with disabilities.

Scale indicators6 records

Recent moves11 records

Expansion highlights6 records

Neuroscape competitors and assessment

Company assessment

Direct peers

  • Akili Interactive Labs: Akili was co-founded by Dr. Adam Gazzaley and commercialized Neuroscape's Neuroracer technology as EndeavorRx and EndeavorOTC — the first FDA-cleared video game treatments for ADHD. Direct peer given the technology origin and indication overlap (pediatric and adult ADHD digital therapeutics).
  • Posit Science: Posit Science develops BrainHQ, a cognitive training platform with peer-reviewed efficacy data across older adults, similar in commercial model and target population to Neuroscape's Body Brain Trainer. Closest analog in the cognitive training category by both mechanism (adaptive exercises) and end market.
  • CogniFit: CogniFit offers a commercial cognitive assessment and brain training platform targeting both healthy users and clinical populations (ADHD, TBI, MS, dementia). Comparable to Neuroscape in combining assessments (similar to ACE/ORCA) with adaptive training games.
  • Cambridge Cognition: Cambridge Cognition develops digital cognitive assessments (CANTAB) used in clinical trials and clinical practice, comparable to Neuroscape's ACE and ORCA assessment tools. Both target CNS clinical trials and clinical decision support markets.
  • Click Therapeutics: Click Therapeutics is a prescription digital therapeutics company developing software-based treatments across migraine, schizophrenia, MDD, and oncology — directly comparable business model (DTx with FDA pathway) to what Neuroscape technologies pursue after licensing.
  • MedRhythms: MedRhythms develops digital therapeutics for neurologic conditions (notably stroke-related walking impairment) using sensor-based rhythmic auditory stimulation. Comparable to Neuroscape's Coherence rhythm training and VR Labyrinth interventions in mechanism (closed-loop audio/motor) and clinical focus.
  • Soterix Medical: Soterix Medical develops non-invasive brain stimulation and neuromodulation devices (tDCS, tACS, HD-tES) used in research and clinical applications. Comparable to Neuroscape's Neuroelectrics-partnered transcranial brain stimulation work in non-invasive brain stimulation hardware.

Broad incumbents

  • Pear Therapeutics: Pear Therapeutics pioneered the prescription digital therapeutics category with FDA-authorized products for substance use disorder, opioid use disorder, and insomnia. Although the company filed for bankruptcy in 2023, it established the regulatory pathway that Neuroscape-licensed products now follow.
  • Brainlab: Brainlab offers surgical planning, imaging, and neuroscience visualization tools used in clinical and research settings, including 3D brain visualization broadly comparable to Neuroscape's Glass Brain platform for real-time brain activity display.

Others

  • Empatica: Empatica develops research-grade wearable biosensors (E4 wristband) used by Neuroscape in the MMBS platform. A technology partner but adjacent peer in physiological-signal-based digital biomarker collection for clinical and consumer health applications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Neuroscape social profiles

Digital presence

Neuroscape financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Neuroscape leadership team

Management profile

Number of profiles

Neuroscape funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Neuroscape M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neuroscape

What does Neuroscape do?

Neuroscape is a UCSF translational neuroscience research center that develops custom-designed, closed-loop video game platforms, mobile cognitive assessment tools, and multimodal biosensing systems to assess and optimize brain function. Its prototypes are validated through clinical research and licensed to industry partners for commercial productization (e.g., Neuroracer → Akili's FDA-cleared EndeavorRx). Core offerings include the Nexus research deployment platform, ACE and ORCA mobile assessments, Glass Brain visualization, and a portfolio of intervention games (Neuroracer, MediTrain, Coherence, Labyrinth, Body Brain Trainer) integrated with the Multimodal Biosensing (MMBS) platform.

Is Neuroscape a public or private company?

Neuroscape is a private company. It is classified as state government owned and is currently operating.

When was Neuroscape founded?

Neuroscape was founded in 2016. It employs 1 to 10 people.

Where is Neuroscape based?

Neuroscape is headquartered in Coimbatore, India, in the Asia region.

How does Neuroscape make money?

Two revenue lines are on record. Research Grants and Philanthropy is the primary driver. The others are technology Licensing.

Who are Neuroscape's main competitors?

Direct peers on record are Akili Interactive Labs, Posit Science, CogniFit, Cambridge Cognition, Click Therapeutics, MedRhythms and Soterix Medical. Broad incumbents are Pear Therapeutics and Brainlab. Empatica is listed as an others.

Does Neuroscape have an API?

No public API is recorded for Neuroscape.

What industry is Neuroscape in?

Neuroscape's product category is Digital Therapeutics Research. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLALAEAJ, Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Digital Health NewsSamsung Launches Beta Version of AI-Powered Health Assistant Across USSamsung has launched a beta version of its AI-powered Health Assistant within the Samsung Health app, now available to eligible users across the US. The assistant provides personalized health guidance and recommendations validated by physicians and certified health coaches, organized around five core wellness pillars: sleep, activity, nutrition, mindfulness, and vitals. The launch is part of Samsung's broader healthcare strategy, which includes the July acquisition of digital health platform Xealth and partnerships with Lark Health and Neuroscape.Samsung Mobile PressNeuroscape and Samsung Partner To Study Cognitive Change Across the LifespanThe Neuroscape research center at UCSF and Samsung are collaborating on the TAH-DA longitudinal study to track cognitive change in adults aged 40-89 across North America using Samsung wearable devices. The study aims to identify biometric predictors of cognitive decline and test digital interventions to boost cognition over a year.Samsung Global NewsroomNeuroscape and Samsung Partner to Study Cognitive Change Across the LifespanAn innovative study initiated by the Neuroscape research center at the University of California, San Francisco, in partnership with Samsung, seeks to examine cognitive changes throughout life using wearable technology. The TAH-DA longitudinal study aims to identify biometric predictors of cognitive decline over a year and is part of Samsung's broader initiative to advance digital health solutions. This initiative represents Samsung's commitment to exploring the connections between brain health and wellness through collaboration with leading institutions.EdsurgeCan a Neuroscience Video Game Treat ADHD?Akili Interactive, backed by UCSF's Neuroscape, is developing Project: Evo, a brain-training video game for ADHD, now in Phase III clinical trials. The company aims to make it the first FDA-approved non-drug treatment for the disorder, which affects 5-10% of school-aged children.